Published in Front Genet on May 15, 2017
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet (2008) 8.51
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet (1997) 5.47
Alzheimer mechanisms and therapeutic strategies. Cell (2012) 5.24
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (2009) 4.92
The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91
Amyloid precursor protein trafficking, processing, and function. J Biol Chem (2008) 4.79
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet (2011) 4.04
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med (1997) 2.95
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
The role of mitochondria in aging. J Clin Invest (2013) 2.71
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem (2005) 2.56
The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med (2016) 2.31
The biology of proteostasis in aging and disease. Annu Rev Biochem (2015) 1.96
Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev (2003) 1.90
Oxidative modification of proteins during aging. Exp Gerontol (2001) 1.90
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci U S A (1997) 1.75
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'. Nat Neurosci (2015) 1.60
Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? Biochem Pharmacol (2012) 1.24
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal (2013) 1.20
Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res Ther (2010) 1.18
Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med (2012) 1.13
Truncated and modified amyloid-beta species. Alzheimers Res Ther (2014) 1.01
Chronic inflammation and amyloidogenesis in Alzheimer's disease -- role of Spirochetes. J Alzheimers Dis (2008) 0.99
Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis. Neurotox Res (2013) 0.97
Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease. Mol Neurobiol (2010) 0.96
Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease. Aging (Albany NY) (2011) 0.95
A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease. Acta Neuropathol Commun (2013) 0.94
Isomerization of Asp7 leads to increased toxic effect of amyloid-β42 on human neuronal cells. Cell Death Dis (2013) 0.94
Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res (2002) 0.90
Heredity in dementia of the Alzheimer type. Clin Genet (1994) 0.87
The Evolution of Genetics: Alzheimer's and Parkinson's Diseases. Neuron (2016) 0.87
Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease. Acta Neuropathol (2014) 0.85
Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin Genet (2006) 0.84
4-Hydroxynonenal (HNE) modified proteins in metabolic diseases. Free Radic Biol Med (2016) 0.80
Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease. CNS Neurol Disord Drug Targets (2014) 0.79
Genomic variants, genes, and pathways of Alzheimer's disease: An overview. Am J Med Genet B Neuropsychiatr Genet (2017) 0.78
Proteostasis collapse, inter-tissue communication, and the regulation of aging at the organismal level. Front Genet (2015) 0.77
The aging brain: protein phosphorylation as a target of changes in neuronal function. Life Sci (1991) 0.76
Citrullination and deamidation affect aggregation properties of amyloid β-proteins. Amyloid (2016) 0.76
Common Polymorphisms Within QPCT Gene Are Associated with the Susceptibility of Schizophrenia in a Han Chinese Population. Mol Neurobiol (2015) 0.76
Association between polymorphisms in the protein L-isoaspartate (D-aspartate) O-methyltransferase gene and premature ovarian failure. Fertil Steril (2008) 0.76
Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo. J Alzheimers Dis (2010) 0.76
[Isomerization of Asp7 increases the toxic effects of amyloid β and its phosphorylated form in SH-SY5Y neuroblastoma cells]. Mol Biol (Mosk) (2016) 0.76
Aging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP. Neurobiol Aging (2016) 0.75